[pubmed] Immune checkpoint inhibitor-induced anti-striational antibodies in myasthenia gravis and myositis: a case repor
Posté : 26 août 2021 12:00
Rinsho Shinkeigaku. 2021 Aug 26. doi: 10.5692/clinicalneurol.cn-001604. Online ahead of print.
ABSTRACT
A 78-year-old man was treated with ipilimumab and nivolumab for advanced renal cell carcinoma with liver and lymph node metastasis. He developed diplopia, ptosis, dysphagia, and weakness of the limbs and neck, 1 month after treatment. Serum creatine kinase (CK) levels were elevated, and neck MRI revealed inflammation of the deep trunk muscles. Although anti-acetylcholine receptor antibody was negative, the edrophonium test was positive. Anti-striational antibodies such as the anti-titin and the anti-muscular voltage-gated potassium channel (Kv 1.4) antibodies (which serve as biomarkers of immune checkpoint inhibitors associated with myasthenia gravis and myositis) were positive (anti-titin antibody titer 11.51, normal
Source: https://pubmed.ncbi.nlm.nih.gov/3443374 ... 3&v=2.14.5